Wedbush Reiterates Outperform on Nuvalent, Maintains $99 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Nuvalent (NASDAQ:NUVL) and maintained a price target of $99.
September 09, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Nuvalent and maintained a price target of $99, indicating confidence in the company's future performance.
The reiteration of an Outperform rating and a maintained price target of $99 by a reputable analyst suggests a positive outlook for Nuvalent. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100